S&P 500   3,404.85 (+0.11%)
DOW   27,614.08 (-0.26%)
QQQ   282.96 (+0.89%)
AAPL   116.40 (+1.17%)
MSFT   214.12 (+1.92%)
FB   283.76 (+2.40%)
GOOGL   1,593.11 (+0.56%)
AMZN   3,273.98 (+2.09%)
TSLA   423.64 (+0.80%)
NVDA   532.64 (+1.33%)
BABA   318.84 (+3.90%)
CGC   18.79 (+1.40%)
GE   7.16 (-2.98%)
MU   52.02 (-0.23%)
AMD   78.20 (-4.90%)
T   27.08 (-1.10%)
F   7.99 (-0.50%)
ACB   4.10 (-6.82%)
GILD   59.87 (-0.15%)
NFLX   487.95 (-0.06%)
NIO   27.65 (+6.31%)
BA   156.86 (-2.47%)
DIS   124.01 (-0.04%)
S&P 500   3,404.85 (+0.11%)
DOW   27,614.08 (-0.26%)
QQQ   282.96 (+0.89%)
AAPL   116.40 (+1.17%)
MSFT   214.12 (+1.92%)
FB   283.76 (+2.40%)
GOOGL   1,593.11 (+0.56%)
AMZN   3,273.98 (+2.09%)
TSLA   423.64 (+0.80%)
NVDA   532.64 (+1.33%)
BABA   318.84 (+3.90%)
CGC   18.79 (+1.40%)
GE   7.16 (-2.98%)
MU   52.02 (-0.23%)
AMD   78.20 (-4.90%)
T   27.08 (-1.10%)
F   7.99 (-0.50%)
ACB   4.10 (-6.82%)
GILD   59.87 (-0.15%)
NFLX   487.95 (-0.06%)
NIO   27.65 (+6.31%)
BA   156.86 (-2.47%)
DIS   124.01 (-0.04%)
S&P 500   3,404.85 (+0.11%)
DOW   27,614.08 (-0.26%)
QQQ   282.96 (+0.89%)
AAPL   116.40 (+1.17%)
MSFT   214.12 (+1.92%)
FB   283.76 (+2.40%)
GOOGL   1,593.11 (+0.56%)
AMZN   3,273.98 (+2.09%)
TSLA   423.64 (+0.80%)
NVDA   532.64 (+1.33%)
BABA   318.84 (+3.90%)
CGC   18.79 (+1.40%)
GE   7.16 (-2.98%)
MU   52.02 (-0.23%)
AMD   78.20 (-4.90%)
T   27.08 (-1.10%)
F   7.99 (-0.50%)
ACB   4.10 (-6.82%)
GILD   59.87 (-0.15%)
NFLX   487.95 (-0.06%)
NIO   27.65 (+6.31%)
BA   156.86 (-2.47%)
DIS   124.01 (-0.04%)
S&P 500   3,404.85 (+0.11%)
DOW   27,614.08 (-0.26%)
QQQ   282.96 (+0.89%)
AAPL   116.40 (+1.17%)
MSFT   214.12 (+1.92%)
FB   283.76 (+2.40%)
GOOGL   1,593.11 (+0.56%)
AMZN   3,273.98 (+2.09%)
TSLA   423.64 (+0.80%)
NVDA   532.64 (+1.33%)
BABA   318.84 (+3.90%)
CGC   18.79 (+1.40%)
GE   7.16 (-2.98%)
MU   52.02 (-0.23%)
AMD   78.20 (-4.90%)
T   27.08 (-1.10%)
F   7.99 (-0.50%)
ACB   4.10 (-6.82%)
GILD   59.87 (-0.15%)
NFLX   487.95 (-0.06%)
NIO   27.65 (+6.31%)
BA   156.86 (-2.47%)
DIS   124.01 (-0.04%)
Log in
NASDAQ:RPRX

Royalty Pharma News Headlines

$37.96
-0.81 (-2.09 %)
(As of 10/27/2020 01:51 PM ET)
Add
Compare
Today's Range
$37.68
Now: $37.96
$38.98
50-Day Range
$38.56
MA: $41.29
$44.81
52-Week Range
$38.10
Now: $37.96
$56.50
Volume21,904 shs
Average Volume1.57 million shs
Market Capitalization$13.89 billion
P/E RatioN/A
Dividend Yield1.54%
BetaN/A

Headlines

Royalty Pharma (NASDAQ RPRX) News Headlines Today

Source:
DateHeadline
Royalty Pharma (NASDAQ:RPRX) Downgraded by Zacks Investment ResearchRoyalty Pharma (NASDAQ:RPRX) Downgraded by Zacks Investment Research
marketbeat.com - September 12 at 7:11 AM
Royalty Pharma (NASDAQ:RPRX) Coverage Initiated at Evercore ISIRoyalty Pharma (NASDAQ:RPRX) Coverage Initiated at Evercore ISI
marketbeat.com - July 14 at 8:26 AM
Royalty Pharma (NASDAQ:RPRX) Sets New 52-Week Low at $37.96Royalty Pharma (NASDAQ:RPRX) Sets New 52-Week Low at $37.96
americanbankingnews.com - October 27 at 12:16 PM
Royalty Pharma PLC (NASDAQ:RPRX) Director Sells $19,454,400.00 in StockRoyalty Pharma PLC (NASDAQ:RPRX) Director Sells $19,454,400.00 in Stock
americanbankingnews.com - October 22 at 11:36 PM
Royalty Pharma (NASDAQ:RPRX) Sets New 1-Year Low at $38.12Royalty Pharma (NASDAQ:RPRX) Sets New 1-Year Low at $38.12
americanbankingnews.com - October 21 at 2:59 PM
Royalty Pharma Announces Closing of Secondary Offering of Class A Ordinary Shares by Selling ShareholdersRoyalty Pharma Announces Closing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders
finance.yahoo.com - October 20 at 5:55 PM
Royalty Pharma PLC (NASDAQ:RPRX) to Issue Quarterly Dividend of $0.15Royalty Pharma PLC (NASDAQ:RPRX) to Issue Quarterly Dividend of $0.15
americanbankingnews.com - October 16 at 5:24 PM
Royalty Pharma prices secondary offering of sharesRoyalty Pharma prices secondary offering of shares
seekingalpha.com - October 16 at 7:59 AM
Royalty Pharma priced secondary offering at $42 per shareRoyalty Pharma priced secondary offering at $42 per share
seekingalpha.com - October 16 at 7:59 AM
Royalty Pharma plc (RPD.MU)Royalty Pharma plc (RPD.MU)
au.finance.yahoo.com - October 13 at 5:18 PM
Royalty Pharma under pressure post secondary offering of sharesRoyalty Pharma under pressure post secondary offering of shares
seekingalpha.com - October 13 at 5:18 PM
New Ventures Funds Rebrands as Scientia VenturesNew Ventures Funds Rebrands as Scientia Ventures
prnewswire.com - October 2 at 9:33 AM
Royalty Pharma plc (NASDAQ:RPRX) Shares Could Be 41% Below Their Intrinsic Value EstimateRoyalty Pharma plc (NASDAQ:RPRX) Shares Could Be 41% Below Their Intrinsic Value Estimate
finance.yahoo.com - September 16 at 1:42 PM
Royalty Pharma Discounted Despite High ROIC Business ModelRoyalty Pharma Discounted Despite High ROIC Business Model
seekingalpha.com - September 9 at 7:46 AM
Royalty Pharma Announces Closing of $6.0 Billion Senior Unsecured NotesRoyalty Pharma Announces Closing of $6.0 Billion Senior Unsecured Notes
finance.yahoo.com - September 2 at 6:54 PM
Royalty Pharma Declares Third-Quarter 2020 DividendRoyalty Pharma Declares Third-Quarter 2020 Dividend
finance.yahoo.com - September 2 at 8:52 AM
Royalty Pharma prices multiple-tranche notes offeringRoyalty Pharma prices multiple-tranche notes offering
seekingalpha.com - August 25 at 2:08 PM
Royalty Pharma prices $6B debt offeringRoyalty Pharma prices $6B debt offering
seekingalpha.com - August 25 at 2:08 PM
Royalty Pharma Announces Pricing of $6.0 Billion Senior Unsecured NotesRoyalty Pharma Announces Pricing of $6.0 Billion Senior Unsecured Notes
finance.yahoo.com - August 25 at 9:05 AM
Royalty Pharma prices $6 billion bond deal that is its first as a public companyRoyalty Pharma prices $6 billion bond deal that is its first as a public company
finance.yahoo.com - August 25 at 9:05 AM
Royalty Pharma Announces Launch of Senior Notes OfferingRoyalty Pharma Announces Launch of Senior Notes Offering
finance.yahoo.com - August 19 at 10:08 AM
How Is Royalty Pharma Poised After Earnings?How Is Royalty Pharma Poised After Earnings?
msn.com - August 12 at 3:10 PM
Royalty Pharma plc (RPRX) CEO Pablo Legorreta on Q2 2020 Results - Earnings Call TranscriptRoyalty Pharma plc (RPRX) CEO Pablo Legorreta on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 12 at 3:10 PM
Institutional Ownership Change Signals Bullish US Stock: $CYCC $RPRX $NCTYInstitutional Ownership Change Signals Bullish US Stock: $CYCC $RPRX $NCTY
marketwatch.com - August 12 at 10:10 AM
Royalty Pharma Reports Second Quarter 2020 ResultsRoyalty Pharma Reports Second Quarter 2020 Results
finance.yahoo.com - August 12 at 10:10 AM
Biohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 MillionBiohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 Million
finance.yahoo.com - August 7 at 10:27 AM
Royalty Pharma Appoints Henry A. Fernandez and Ted W. Love, M.D. to the Company’s Board of DirectorsRoyalty Pharma Appoints Henry A. Fernandez and Ted W. Love, M.D. to the Company’s Board of Directors
finance.yahoo.com - August 3 at 6:01 PM
Royalty Pharma to acquire a portion of PTC’s royalty interest in risdiplam for $650MRoyalty Pharma to acquire a portion of PTC’s royalty interest in risdiplam for $650M
seekingalpha.com - July 20 at 8:48 AM
Royalty Pharma Acquires Royalty Interest in Risdiplam From PTC TherapeuticsRoyalty Pharma Acquires Royalty Interest in Risdiplam From PTC Therapeutics
finance.yahoo.com - July 20 at 8:48 AM
Keep an Eye on Royalty Pharma Stock, 2020’s Biggest IPOKeep an Eye on Royalty Pharma Stock, 2020’s Biggest IPO
investorplace.com - July 2 at 1:10 PM
Dun & Bradstreet Trades Higher After IPO Raised $1.7 BillionDun & Bradstreet Trades Higher After IPO Raised $1.7 Billion
finance.yahoo.com - July 1 at 2:37 PM
After a strong run, whats next for investors in Repros Therapeutics Inc?After a strong run, what's next for investors in Repros Therapeutics Inc?
uk.finance.yahoo.com - June 30 at 11:25 PM
Cerberus Heads for an Exit at Grocer Albertsons After 14 YearsCerberus Heads for an Exit at Grocer Albertsons After 14 Years
finance.yahoo.com - June 25 at 2:38 PM
New Ventures Portfolio Company, Royalty Pharma, Surges On Public DebutNew Ventures Portfolio Company, Royalty Pharma, Surges On Public Debut
finance.yahoo.com - June 25 at 9:37 AM
Meet the Pharma Company That Just Had a Bigger IPO Than ModernasMeet the Pharma Company That Just Had a Bigger IPO Than Moderna's
www.nasdaq.com - June 23 at 8:32 AM
PreMarket Prep Stock Of The Day: Royalty PharmaPreMarket Prep Stock Of The Day: Royalty Pharma
www.benzinga.com - June 18 at 12:52 PM
Nasdaq President Nelson Griggs on the 2020 IPO marketNasdaq President Nelson Griggs on the 2020 IPO market
finance.yahoo.com - June 16 at 6:12 PM
Royalty Pharma plc Rings the Opening Bell in Celebration of its IPORoyalty Pharma plc Rings the Opening Bell in Celebration of its IPO
www.nasdaq.com - June 16 at 1:09 PM
Royalty Pharma IPO prices at top of range in biggest 2020 U.S. listing -sourcesRoyalty Pharma IPO prices at top of range in biggest 2020 U.S. listing -sources
finance.yahoo.com - June 15 at 7:45 PM
Repros Therapeutics Inc.® Reports Second Quarter 2017 Financial ResultsRepros Therapeutics Inc.® Reports Second Quarter 2017 Financial Results
www.bloomberg.com - May 25 at 10:27 PM
Repros Therapeutics Inc.® Reports First Quarter 2017 Financial ResultsRepros Therapeutics Inc.® Reports First Quarter 2017 Financial Results
www.bloomberg.com - May 23 at 12:41 AM
Repros Therapeutics (RPRX) - Income StatementRepros Therapeutics (RPRX) - Income Statement
www.fool.com - March 28 at 12:09 AM
Gonadotropin Releasing Hormone Market Size, Share, Development by 2026Gonadotropin Releasing Hormone Market Size, Share, Development by 2026
www.marketwatch.com - January 18 at 8:56 AM
Why Repros Therapeutics (RPRX) Stock Plummeted to a One-Year Low TodayWhy Repros Therapeutics (RPRX) Stock Plummeted to a One-Year Low Today
www.thestreet.com - October 9 at 8:14 PM
This page was last updated on 10/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.